Mucormycosis, the COVID-19 factor and the pressing need for new treatments

Prior to 2021, textbooks about fungal diseases would classify mucormycosis as a very rare infection. However, for the immunosuppressed, mucormycosis presents a severe and, in many cases, fatal invasive fungal infection. The disease is caused by exposure to mucor mold, a fungus common to soil, plants, manure and decaying fruits and vegetables, as well as rural air, around the world. In addition, recovery of mucor from the mucus of healthy people is not uncommon. However, the unusual circumstances attributable to the coronavirus pandemic have resulted in the fungal infection reaching prominence in countries like India. There has been a large...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!